Basic Information
Curapath is a leading developer of GMP-grade polyamino acids (PAA) and lipid nanoparticle encapsulation technologies for advanced drug delivery applications, including mRNA, DNA, cell therapy, gene therapy, biologics, vaccines, and small molecule therapies. The team of expert biochemists and polymer material scientists at Curapath are key partners in the drug development and commercialization processes of some of the world’s leading therapeutic companies. The company offers contract development and manufacturing services, including preclinical development, analytical characterization, technology transfer, GMP manufacturing, and fill/finish services.